Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma.
Wang D, Gaba RC, Jin B, Lewandowski RJ, Riaz A, Memon K, Ryu RK, Sato KT, Kulik LM, Mulcahy MF, Larson AC, Salem R, Omary RA. Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology. 2014 Aug; 272(2):587-97.
-
Adult
-
Adult
-
Aged
-
Aged
-
Aged, 80 and over
-
Aged, 80 and over
-
Angiography, Digital Subtraction
-
Angiography, Digital Subtraction
-
Antineoplastic Agents
-
Antineoplastic Agents
-
Biomarkers
-
Biomarkers
-
Biopsy
-
Biopsy
-
Carcinoma, Hepatocellular
-
Carcinoma, Hepatocellular
-
Chemoembolization, Therapeutic
-
Chemoembolization, Therapeutic
-
Contrast Media
-
Contrast Media
-
Female
-
Female
-
Gadolinium DTPA
-
Gadolinium DTPA
-
Humans
-
Humans
-
Liver Function Tests
-
Liver Function Tests
-
Liver Neoplasms
-
Liver Neoplasms
-
Magnetic Resonance Angiography
-
Magnetic Resonance Angiography
-
Magnetic Resonance Imaging, Interventional
-
Magnetic Resonance Imaging, Interventional
-
Male
-
Male
-
Middle Aged
-
Middle Aged
-
Predictive Value of Tests
-
Predictive Value of Tests
-
Prospective Studies
-
Prospective Studies
-
Survival Rate
-
Survival Rate
-
Treatment Outcome
-
Treatment Outcome
-
Tumor Burden
-
Tumor Burden